Two top executives selling in the same window, with one exercising and immediately flipping options, is a cautionary signal. Monitor for upcoming clinical data readouts, earnings, or corporate events that may have prompted the selling. The stock has rallied strongly (T+5 +5.4%, T+20 +13.5% on prior neutral reports), so this cluster may indicate insiders taking profits near recent highs.
Price Chart
Executive Summary
Two top executives at Entrada Therapeutics sold a combined $629K in open-market sales over a 7-day window, with President & COO Dowden also exercising and immediately selling derivative shares. The total sales represent ~0.11% of market cap, a modest but notable cluster involving both the COO and R&D President, suggesting insider caution ahead of potential catalysts or data readouts.
Key Financial Metrics
Key Facts
- President & COO Nathan Dowden sold 15,000 shares at $15.33 for $230K on May 4, 2026
- President of R&D Sethuraman Natarajan sold 25,907 shares at $15.39 for $399K on May 4, 2026
- Dowden also exercised 15,000 derivative shares at $1.74 ($26,100 cost) and immediately sold them
- Total open-market sales: $629K, representing ~0.11% of $563M market cap
- Cluster occurred in a 7-day window ending May 4, 2026
- No insider purchases were reported in this cluster
Financial Impact
Total insider sales of $629K, ~0.11% of market cap
Risk Factors
- Insider selling by both COO and R&D President may signal lack of near-term catalysts or concerns about upcoming data
- Derivative exercise and immediate sale suggests monetization rather than conviction holding
- Stock has appreciated significantly in recent months, increasing risk of mean reversion
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TRDA-1777937131163 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | Insider Cluster | $6.42 $6.90 | ▼ −7.48% | ▼ −7.98% | $5.38 (+16.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $7.17 $6.80 | ▼ −5.16% | ▼ −4.01% | $5.38 (−24.97%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 27, 2026 5w ago | Insider Cluster | $7.27 $7.17 | ▼ −1.38% | ▼ −1.64% | $5.38 (−26.00%) |
Aug 10, 2026 7w ago | Insider Cluster | $7.04 $7.27 | ▲ +3.27% | ▲ +3.67% | $5.38 (−23.58%) |
Aug 5, 2026 8w ago | 8-K | $7.06 $7.67 | ▲ +8.64% | ▲ +8.29% | $5.38 (−23.80%) |
Aug 3, 2026 8w ago | Insider Cluster | $7.24 $7.04 | ▼ −2.76% | ▼ −2.66% | $5.38 (−25.69%) |
Jul 30, 2026 9w ago | 144 | $6.79 $6.87 | ▼ −1.18% | ▲ +2.33% | $5.38 (+20.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access